SI-BONE Financials - Benzinga

SI-BONE Inc

SIBNNASDAQ

Trade with Public

Trade with Public

$19.15

0.392.08%

가까이에: Sep 28, 5:00 PM EST

$19.15

0.392.08%

프리마켓: 4:08 AM EST

개요 뉴스 실적 전망 이벤트 목표가재무심리 지분 현황 비교 옵션 주식 보고서

SI-BONE Financials

SI-BONE (SIBN) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
SI-BONE Raises FY2026 Sales Guidance from $230.000M-$233.000M to $231.000M-$233.000M vs $231.775M Est

SI-BONE (NASDAQ:SIBN) raises FY2026 sales outlook from $230.000 million-$233.000 million to $231.000 million-$233.000 million vs $231.775 million estimate.

Benzinga Newsdesk

PRO
SI-BONE Q2 EPS $(0.09) Beats $(0.15) Estimate, Sales $56.010M Beat $55.335M Estimate

SI-BONE (NASDAQ:SIBN) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.15) by 40 percent. This is a 35.71 percent increase over losses of $(0.14) per share from the same

Benzinga Newsdesk

PRO
SI-BONE Raises FY2026 Sales Guidance from $228.500M-$232.500M to $230.000M-$233.000M vs $230.387M Est

SI-BONE (NASDAQ:SIBN) raises FY2026 sales outlook from $228.500 million-$232.500 million to $230.000 million-$233.000 million vs $230.387 million estimate.

Benzinga Newsdesk

PRO
SI-BONE Q1 EPS $(0.10) Beats $(0.18) Estimate, Sales $52.588M Beat $51.105M Estimate

SI-BONE (NASDAQ:SIBN) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.18) by 44.44 percent. This is a 33.33 percent increase over losses of $(0.15) per share from the same

Benzinga Newsdesk

Earnings Scheduled For May 11, 2026

Benzinga Insights

SI-BONE Q4 Earnings Assessment

Benzinga Insights

© 2026 Benzinga | All Rights Reserved